Squarepoint’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,756
Closed -$47.1K 2732
2025
Q1
$47.1K Sell
15,756
-34,994
-69% -$105K ﹤0.01% 2619
2024
Q4
$170K Buy
50,750
+35,053
+223% +$117K ﹤0.01% 2427
2024
Q3
$52.6K Buy
15,697
+1,057
+7% +$3.54K ﹤0.01% 2432
2024
Q2
$48.5K Sell
14,640
-5,513
-27% -$18.2K ﹤0.01% 2366
2024
Q1
$81.4K Buy
+20,153
New +$81.4K ﹤0.01% 2277
2023
Q4
Sell
-41,308
Closed -$124K 2500
2023
Q3
$124K Buy
41,308
+22,117
+115% +$66.4K ﹤0.01% 2224
2023
Q2
$71.8K Sell
19,191
-3,586
-16% -$13.4K ﹤0.01% 2253
2023
Q1
$76.3K Sell
22,777
-16,237
-42% -$54.4K ﹤0.01% 2069
2022
Q4
$188K Buy
+39,014
New +$188K ﹤0.01% 1908
2022
Q1
Sell
-213,220
Closed -$1.91M 2227
2021
Q4
$1.91M Buy
+213,220
New +$1.91M 0.01% 897